SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-031549
Filing Date
2015-05-15
Accepted
2015-05-15 16:05:18
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v410107_10q.htm 10-Q 397430
2 EXHIBIT 31.1 v410107_ex31-1.htm EX-31.1 10744
3 EXHIBIT 31.2 v410107_ex31-2.htm EX-31.2 11537
4 EXHIBIT 32.1 v410107_ex32-1.htm EX-32.1 5428
  Complete submission text file 0001144204-15-031549.txt   4002211

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20150331.xml EX-101.INS 502182
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20150331.xsd EX-101.SCH 38520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20150331_cal.xml EX-101.CAL 35959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20150331_def.xml EX-101.DEF 203309
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20150331_lab.xml EX-101.LAB 264686
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20150331_pre.xml EX-101.PRE 244106
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 15869201
SIC: 2834 Pharmaceutical Preparations